• LAST PRICE
    16.1900
  • TODAY'S CHANGE (%)
    Trending Down-0.0400 (-0.2465%)
  • Bid / Lots
    16.1200/ 7
  • Ask / Lots
    16.2700/ 7
  • Open / Previous Close
    16.1700 / 16.2300
  • Day Range
    Low 15.9000
    High 16.5800
  • 52 Week Range
    Low 10.6004
    High 29.6000
  • Volume
    191,876
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 16.23
TimeVolumeTYRA
09:32 ET172616.355
09:35 ET10016.58
09:42 ET30016.34
09:46 ET10016.34
09:57 ET10016.33
10:00 ET20016.42
10:04 ET130016.4
10:13 ET80016.4
10:15 ET157916.4
10:18 ET30016.435
10:20 ET60016.315
10:22 ET50016.315
10:24 ET10016.4
10:27 ET30016.375
10:29 ET20016.37
10:31 ET95316.255
10:33 ET137116.2125
10:36 ET30016.3
10:38 ET20016.3
10:40 ET48516.3
10:42 ET10016.3
10:44 ET11416.235
10:45 ET20016.235
10:47 ET10016.3
10:49 ET259316.24
10:51 ET80016.225
10:54 ET290016.21
10:56 ET30016.21
10:58 ET30016.21
11:00 ET24616.24
11:02 ET60016.26
11:03 ET2411516.15
11:09 ET10016.13
11:14 ET1032715.9
11:18 ET40015.95
11:20 ET30015.97
11:23 ET10015.97
11:30 ET27315.94
11:36 ET230016.13
11:38 ET20016.085
11:39 ET50016.095
11:41 ET58716.09
11:43 ET68016.09
11:45 ET10016.09
11:48 ET180016.09
11:50 ET62216.095
11:52 ET228016.09
11:54 ET60016.13
11:56 ET10016.15
11:59 ET160016.06
12:01 ET60016.09
12:03 ET30016.09
12:06 ET36316.11
12:08 ET90816.1
12:10 ET170016.085
12:12 ET247916.09
12:14 ET440016.1
12:15 ET30016.1
12:21 ET50016.09
12:24 ET87216.185
12:26 ET14516.205
12:28 ET20016.2
12:30 ET30016.2
12:32 ET157016.29
12:33 ET54816.25
12:35 ET15016.2805
12:37 ET670016.27
12:42 ET20016.24
12:44 ET20016.21
12:46 ET20016.23
12:51 ET20016.17
12:53 ET40016.17
12:55 ET58316.145
12:57 ET10016.13
01:00 ET23216.07
01:06 ET80016.16
01:08 ET10016.115
01:09 ET10016.11
01:11 ET10016.13
01:27 ET10016.115
01:29 ET72816.16
01:31 ET40016.17
01:33 ET30016.16
01:36 ET63516.15
01:49 ET10016.18
01:51 ET80016.1
01:54 ET171016.15
01:56 ET40016.16
01:58 ET10016.12
02:02 ET10016.1
02:09 ET130016.18
02:16 ET180016.31
02:18 ET110016.27
02:23 ET5235416.175
02:25 ET136216.19
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTYRA
Tyra Biosciences Inc
821.3M
-10.1x
---
United StatesDNTH
Dianthus Therapeutics Inc
821.3M
-11.1x
---
United StatesREPL
Replimune Group Inc
854.0M
-3.7x
---
United StatesMBX
MBX Biosciences Inc
785.3M
-15.7x
---
United StatesAVXL
Anavex Life Sciences Corp
775.9M
-18.3x
---
United StatesBIOA
BIOAGE Labs Inc
774.6M
-11.3x
---
As of 2024-11-12

Company Information

Tyra Biosciences, Inc. is a clinical-stage biotechnology company. It is focused on developing precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. Its in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations to cause acquired resistance to existing therapies. Its initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. Its lead product candidate, TYRA-300, is an investigational, oral, FGFR3-selective inhibitor being evaluated in an international, multi-center, open label Phase 1 clinical study, SURF301. Its second oncology product candidate, TYRA-200, is an investigational, oral, FGFR1/2/3 inhibitor with potency against activating FGFR2 gene alterations, and clinically important molecular brake and gatekeeper resistance mutations.

Contact Information

Headquarters
2656 State StreetCARLSBAD, CA, United States 92008
Phone
619-728-4760
Fax
302-655-5049

Executives

Non-Executive Chairman of the Board
Robert More
President, Chief Executive Officer, Treasurer, Director
Todd Harris
Chief Financial Officer
Alan Fuhrman
Chief Operating Officer
Daniel Bensen
Chief Medical Officer
Douglas Warner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$821.3M
Revenue (TTM)
$0.00
Shares Outstanding
50.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.61
Book Value
$4.75
P/E Ratio
-10.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.